NAVIGATE – Improving survival in vulnerable lung cancer patients through individual support: a multicenter randomized controlled trial
Novo Nordisk Foundation
Kræftens Bekæmpelse
Research shows that there are social differences in lung cancer prognosis, which can be explained by late diagnosis, poor physical condition, comorbidity, and low completion of treatment. In the NAVIGATE study, we wish address the social differences in lung cancer survival through a new supportive program where nurse navigators will guide and support vulnerable lung cancer patients before, during and after their cancer treatment. The nurse-led program holds three components: 1) support in completion of treatment and in self-managing symptoms and referral to health services 2) regular reporting of physical and psychological symptoms and 3) exercise training and support in health behavior change. We will evaluate the effect of the program on overall survival, treatment completion, symptom burden and health related quality of life in a randomized controlled trial inviting all lung cancer departments in Denmark.
Postdoc / Fellowships / Award